[ Price : $8.95]
FDA clears an ArtVentive Medical Group 510(k) for its Endoluminal Occlusion System that is intended for use in the peripheral vasc...[ Price : $8.95]
FDA approves an Incyte Corp. supplemental NDA for Jakafi (ruxolitinib) for treating patients with polycythemia vera, a chronic typ...[ Price : $8.95]
FDA clears a Fiagon AG 510(k) for its ear, nose and throat Extended Instrument Set.[ Price : $8.95]
The Senate approves unanimously legislation adding Ebola as a qualifying disease for the FDA priority review voucher program.[ Price : $8.95]
Three FDAers make the case for randomized, controlled trials rather than an historical control in evaluating potential Ebola thera...[ Price : $8.95]
Stakeholders call on FDA to look for new ways to educate healthcare providers about REMS.[ Price : $8.95]
FDA issues a final rule and draft guidance on drug and biological product labeling for pregnancy and lactation information.[ Price : $8.95]
FDA commissioner Margaret Hamburg discusses the improving representation of women in clinical trials.